Literature DB >> 16981230

Risk of local adverse events by gender following cardiac catheterization.

Dale R Tavris1, Beverly Albrecht Gallauresi, Syamal Dey, Ralph Brindis, Kristi Mitchel.   

Abstract

PURPOSE: To assess the reason for the relative high risk of local complications for women following cardiac catheterization by evaluating the associations between gender, sheath size, and local adverse outcomes following cardiac catheterization.
METHODS: The data used in this study were obtained from a portion of the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR), which included 13 878 patients who underwent cardiac catheterization at one of 59 participating cardiac catheterization institutions throughout the United States during late 2003. Rates of serious local vascular adverse events were calculated by gender following cardiac catheterization, by type of vascular hemostasis used, stratified by arterial sheath size.
RESULTS: Serious local vascular events were reported in 3.54% of patients, most commonly hematoma (2.00%). The relative risk for women of any vascular complication was 1.40 [95%CI = 1.17, 1.67, p = 0.0002]. A statistically significant relative risk for woman was evident when collagen plug devices or manual compression alone were used as the first method for hemostasis. The rate of vascular complications increased progressively with increasing sheath size, more so in women than in men.
CONCLUSIONS: High relative risk for women of local vascular complications following cardiac catheterization was demonstrated with use of manual compression, as well as with collagen plug devices to control femoral artery bleeding. Large sheath size is associated with both a relatively high absolute risk and a high relative risk for women. Knowledge of this information should be considered by interventional cardiologists in making decisions on how to achieve hemostasis following cardiac catheterization.

Entities:  

Mesh:

Year:  2007        PMID: 16981230     DOI: 10.1002/pds.1307

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  9 in total

1.  Enrollment and monitoring of women in post-approval studies for medical devices mandated by the Food and Drug Administration.

Authors:  Ellen Pinnow; Naomi Herz; Nilsa Loyo-Berrios; Michelle Tarver
Journal:  J Womens Health (Larchmt)       Date:  2014-01-09       Impact factor: 2.681

2.  Gender related differences in predictors of vascular complications: role of vessel size and BMI.

Authors:  Bina Ahmed; Stefan Lischke; Mike De Sarno; Leigh Ann Holterman; Faye Straight; Harold L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 3.  Acute Coronary Syndromes: Differences in Men and Women.

Authors:  Kris R Kawamoto; Melinda B Davis; Claire S Duvernoy
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

Review 4.  ST-Segment Elevation Myocardial Infarction: Sex Differences in Incidence, Etiology, Treatment, and Outcomes.

Authors:  Tayyab Shah; Sohum Kapadia; Alexandra J Lansky; Cindy L Grines
Journal:  Curr Cardiol Rep       Date:  2022-03-14       Impact factor: 2.931

5.  Percutaneous Ultrasound-Guided Carotid Access and Puncture Closure with Angio-Seal in Horses.

Authors:  Arantza Vitoria; Alicia Laborda; Carolina Serrano-Casorrán; Sara Fuente; Antonio Romero; Francisco José Vázquez
Journal:  Animals (Basel)       Date:  2022-06-07       Impact factor: 3.231

6.  Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry.

Authors:  Stacie L Daugherty; Lauren E Thompson; Sunghee Kim; Sunil V Rao; Sumeet Subherwal; Thomas T Tsai; John C Messenger; Frederick A Masoudi
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

7.  Prospective comparison of angio-seal versus manual compression for hemostasis after neurointerventional procedures under systemic heparinization.

Authors:  H-F Wong; C-W Lee; Y-L Chen; Y-M Wu; H-H Weng; Y-H Wang; H-M Liu
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-02       Impact factor: 3.825

8.  [Percutaneous coronary angioplasty in women: clinical, procedural and prognostic features].

Authors:  Leila Abid; Morched Hadrich; Mohamed Sahnoun; Samir Kammoun
Journal:  Pan Afr Med J       Date:  2011-08-24

9.  The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update.

Authors:  Merina Elahi; Noha Eshera; Nkosazana Bambata; Helen Barr; Beverly Lyn-Cook; Julie Beitz; Maria Rios; Deborah R Taylor; Marilyn Lightfoote; Nada Hanafi; Lowri DeJager; Paddy Wiesenfeld; Pamela E Scott; Emmanuel O Fadiran; Marsha B Henderson
Journal:  J Womens Health (Larchmt)       Date:  2016-02-12       Impact factor: 2.681

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.